BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the trea...
Q2 2026
Aug 4, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Oct 29, 2025